BASOPHILE ACTIVATION TEST FOR THE DIAGNOSTICS OF FUNGAL SENSITIZATION IN THE PATIENTS WITH CYSTIC FIBROSIS

Aspergillus fumigatus colonization in the patients with cystic fibrosis (CF) may cause sensitization against A. fumigatus and/or allergic bronchopulmonary aspergillosis (ABPA), which significantly worsens the course of underlying disease. At the present time, new diagnostic tests are searched for detection of fungal sensitization in these patients. The aim of this work was to evaluate an opportunity of application of basophile activation test with A. fumigatus allergen in vitro using flow cytometry, aiming for identification of fungal sensitization in the CF patients. The study included 190 patients with CF aged 1 to 37 years. All the patients underwent common allergy screening (skin tests with fungal allergens, determination of serum levels of total IgE and specific IgE for the fungal allergens), and mycological examination (microscopy and culture of respiratory substrates). Computed tomography of the chest was performed upon clinical indications. The basophil activation test with the A. fumigatus allergen was performed in 10 CF patients with ABPA, and 10 CF patients without ABPA, in addition to the standard allergological examination. Frequency of sensitization to A. fumigatus in the patients with cystic fibrosis was 27%, the incidence of allergic bronchopulmonary aspergillosis was 5.7%. The number of eosinophils, total IgE and specific IgE levels in CF patients with ABPA were significantly higher than in CF patients without ABPA. In blood of the ABPA patients we have identified 68.5 (52.5-81.5%) of basophilic leukocytes activated by A. fumigatus allergen, with a stimulation index of 17.07 (10.30-27.70). In appropriate comparison group, the stimulation index did not exceed 1.5 (p = 0.000). Direct positive correlation between the levels of specific IgE to A. fumigatus and the number of basophils activated by A. fumigatus allergens was revealed (r = 0.77; р < 0.05). FVC values and the body mass index in CF patients with ABPA were significantly lower when compared with the patients without fungal sensitization. Introduction of the basophil activation test, along with standard techniques, may enable a more differentiated assessment of ABPA development in CF patients. Timely detection of associations between A. fumigatus sensitization and clinical status of CF patients will facilitate early and effective administration of specific therapy.

1. Kozlova Ya.I., Uchevatkina A.E., Bychkova N.V., Filippova L.V., Aak O.V., Pyatakova A.V., Frolova E.V., Davydova N.I., Klimko N.N. Basophil activation test in the diagnosis of allergic bronchopulmonary aspergillosis. Problemy meditsinskoy mikologii = Problems in Medical Mycology, 2016, Vol. 18, no. 3, pp. 7-11. (In Russ.)

2. Krasovsky S.А., Samoylenko V.А., Аmelina E.L. Cystic fibrosis: Diagnosis, clinic, basic principles of therapy. Pulmonologiya i allergologiya = Pulmonology and Allergology, 2013, no. 1, pp. 42-46. (In Russ.)

3. Agarwal R., Chakrabarti A., Shah A., Gupta D., Meis J.F., Guleria R., Moss R., Denning D.W. For the ABPA complicating asthma ISHAM working group 2013. Allergic bronchopulmonary aspergillosis: Review of literature and proposal of new diagnostic and classification criteria. Clin. Exp. Allergy, 2013, Vol. 43, no. 8, pp. 850-873.

4. Baxter C.G., Dunn G., Jones A.M., Webb K., Gore R., Richardson M.D., Denning D.W. Novel immunologic classification of aspergillosis in adult cystic fibrosis. J. Allergy Clin. Immunol., 2013, Vol. 132, no. 3, pp. 560-566.

5. Baxter C.G., Moore C.B., Jones A.M., Webb A.K., Denning D.W. IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis. Chest, 2013, Vol. 143, no. 5, pp. 1351-1357.

6. Boumiza R., Debard A.L., Monneret G. The basophil activation test by flow cytometry: Recent development in clinical studies, standardization and emerging perspectives. Clin. Mol. Allergy, 2005, no. 3, pp. 9-13.

7. Chirumbolo S., Vella A., Ortolani R., de Gironcoli M., Solero P., Tridente G., Bellavite P. Differential response of human basophil activation markers: a multiparameter flow cytometry approach. Clin. Mol. Allergy, 2008, no. 6, pp. 12-16.

8. Chotirmall S.H., McElvaney N.G. Fungi in the cystic fibrosis lung: Bystanders or pathogens? Int. J. Biochem. Cell Biol., 2014, no. 52, pp. 161-173.

9. Chirumbolo S.H. Basophil activation test in allergy: time for an update? Int. Arch. Allergy Immunol., 2012, no. 158, pp. 99-114.

10. Chotirmall S.H., Branagan P., Gunaratnam C., McElvaney N.G. Aspergillus/allergic bronchopulmonary aspergillosis in an Irish cystic fibrosis population: A diagnostically challenging entity. Respir. Care, 2012, Vol. 53, no. 8, pp. 1035-1041.

11. Delhaes L., Monchy S., Fréalle E., Hubans C., Salleron J., Leroy S., Prevotat A., Wallet F., Wallaert B., Dei-Cas E., Sime-Ngando T., Chabé M., Viscogliosi E. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community – implications for therapeutic management. PLoS ONE, 2012, Vol. 7, no. 4, e36313. doi: 10.1371/journal.pone.0036313.

12. Denning D.W., Pashley C., Hartl D., Wardlaw A., Godet C., del Giacco S., Delhaes L., Sergejeva S. Fungal allergy in asthma-state of the art and research needs. Clin. Transl. Allergy. 2014, Vol. 4, p. 14.

13. Farrell Ph.M., White T.B., Ren Cl.L., Hempstead S.E., Accurso F., Derichs N., Howenstine M., McColley S.A., Rock M., Rosenfeld M., Sermet-Gaudelus I., Southern K.W., Marshall B.C., Sosnay P.R. Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation. J. Pediatr., 2017, Vol. 181, pp. 4-15.

14. Fillaux J., Bremont F., Murris M., Cassaing S., Rittie J-L., Tetu L., Segonds C., Abbal M., Bieth E., Berry A., Pipy B., Magnaval J-F. Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients. Scand. J. Infect. Dis., 2012, Vol. 44, no. 11, pp. 842-847.

15. Janahi I.A., Rehman A., Al-Naimi A.R. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Ann. Thorac. Med., 2017, Vol. 12, no. 2, pp. 74-82.

16. Karasuyama H., Tsujimura Y., Оbata K., Mukai K. Role for basophils in systemic anaphylaxis. Anaphylaxis. Chem. Immunol. Allergy, 2010, Vol. 95, pp. 85-97.

17. Kang M.G., Song W.J., Park H.K., Lim K.H., Kim S.J., Lee S.Y., Kim S.H., Cho S.H., Min K.U., Chang Y.S. Basophil activation test with food additives in chronic urticaria patients. Clin. Nutr. Res., 2014, Vol. 3, no. 1, pp. 9-16.

18. Knutsen A.P., Kariuki B., Consolino J.D., Warrier M.R. IL-4 alpha chain receptor (IL-4R alpha) polymorphisms in allergic bronchopulmonary aspergillosis. Clin. Mol. Allergy, 2006, no. 4, p. 3.

19. Maturu V.N., Agarwal R. Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: Systematic review and meta-analysis. Clin. Exp. Allergy, 2015, Vol. 45, no. 12, pp. 1765-1778.

20. Mircovic B., Lavelle G.M., Abdul Azim A., Helma K., Gargoum F.S., Molloy K., Gernez Y., Dunne K., Renwick J., Murphy P., Moss R.B., Greene C.M., Gunaratnam C., Chotirmall S.H., McElvaney N.G. The Basophil surface marker CD203с identifies Aspergillus species sensitization in patients with cystic fibrosis. J. Allergy Clin. Immunol., 2016, Vol. 137, no. 2, pp. 436-443.

21. McMahon M.A., Chotirmall S.H., McCullagh B., Branagan P., McElvaney N.G., Logan P.M. Radiological abnormalities associated with Aspergillus colonization in a cystic fibrosis population. Eur. J. Radiol., 2012, Vol. 81, no. 3, pp. e197-202.

22. Oppenheimer J., Nelson H.S. Skin testing. Ann. Allergy Asthma Immunol., 2006, Vol. 96, no. 2, pp. 6-12.

23. Peetermans M., Goeminne P., de Boeck C., Dupont L.J. IgE sensitization to Aspergillus fumigatus is not a bystander phenomenon in cystic fibrosis lung disease. Chest, 2014, Vol. 146, pp. 99-100.

24. Sabino R., Ferreira J.A.G., Moss R.B., Valente J., Veríssimo C., Carolino E., Clemons K.V., Everson C., Banaei N., Penner J., Stevens D.A. Molecular epidemiology of Aspergillus collected from cystic fibrosis patients. J. Cyst. Fibros., 2015, Vol. 14, pp. 474-481.

25. Stevens D. A., Moss R.B., Kurup V.P., Knutsen A.P., Greenberger P., Judson M.A., Denning D.W., Crameri R., Brody A.S., Light M., Skov M., Maish W., Mastella G. Participants in the Cystic Fibrosis Foundation Consensus Conference. Allergic bronchopulmonary aspergillosis in cystic fibrosis – state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin. Infect. Dis., 2003, Vol. 37, Suppl. 3, pp. 225-264.

26. Williams C., Ranjendran, R., Ramage G. Pathogenesis of fungal infections in cystic fibrosis. Curr. Fungal Infect. Rep., 2016, Vol. 10, pp. 163-169.